Ignyta, Inc. (Nasdaq: RXDX), a precision oncology
biotechnology company, today announced that its Chief Medical Officer,
Adrian Senderowicz, M.D., has been selected to serve as Workshop
Planning Committee Chair for the workshop entitled Policy Issues in
the Development and Adoption of Molecularly Targeted Therapies for Cancer .
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.